• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 24th October 2018

Securing Funds for the Proposed NHS Multi-year Funding: The Feasibility of Using a Hypothecated Tax

This new publication sets out the arguments in favour and against the introduction of a hypothecated tax to fund the UK National Health Service (NHS).   In June 2018 the UK Government announced an increase of 3.4% per annum in…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

This new publication sets out the arguments in favour and against the introduction of a hypothecated tax to fund the UK National Health Service (NHS).

 

In June 2018 the UK Government announced an increase of 3.4% per annum in spending on the NHS in England for each of three years. It indicated that taxes will rise to pay for this. Debate has increased as to whether a separate (hypothecated) tax should be introduced to fund the NHS. The Kings Fund has published this year on the topic. OHE published an academic review sometime ago.

This OHE publication by Nick Timmins, a senior fellow at the Institute for Government and the Kings Fund, sets out arguments in favour and against. It is based on the seminar he gave at OHE in July 2018. The issues he explores include:

  • The argument that hypothecation will bring greater stability, transparency and public support;
  • Which tax(es) might be suitable?
  • Possible distortions in public expenditure that might result;
  • Dealing with shortfalls and surpluses;
  • UK experiences of revenue hypothecation in the past, distinguishing soft (non-binding) approaches such as Vehicle Excise Duty, and hard (binding) pots such as National Insurance, neither of which have held.

He concludes by quoting a John Appleby blog which argues that the key decision is to agree (or not) to spend more money on the NHS. Creating a new tax is a distraction from this.

I would point out that Layard in an earlier BMJ Soundcloud debate with Appleby makes the point that the existence of the hypothecated tax will change the nature of the political debate about NHS funding. Of course, even if one accepts that argument, the practical issues Nick Timmins raises still have to be addressed.

Nick Timmins OHE Seminar Briefing is available here.

Citation

Timmins, N. (2018) Securing Funds for the Proposed NHS Multi-year Funding: The Feasibility of Using a Hypothecated Tax. London: Office of Health Economics. 

Related research

Jones, A. and Duncan, A. (1995) Hypothecated taxes: an evaluation of recent proposals. London: Office of Health Economics. 
 
Murray, R. (2018) Hypothecated funding for health and social care: how might it work? London: The King’s Fund.
 
Recent publications
 
Chalkley, M. and Sussex, J. (2018) Private Provision of Publicly Funded Health Care: The Economics of Ownership. London: Office of Health Economics.
 
Ferraro, F. and O’Neill, P. et al. (2018) Measurement of Medicines Expenditure in the Context of the 2014-18 PPRS. London: Office of Health Economics.
 
Sampson, C., O’Neill, P. and Lorgelly, P. (2018) The Impact of New Medicines in the NHS: 70 Years of Innovation. London: Office of Health Economics.
 
  • Healthcare Systems
  • Seminar Briefing

Related News

  • News
  • February 2019

Pricing and Paying for Cures: Early Experience with HTA of Gene Therapy in the USA

Read more
OHgraph
  • News
  • May 2018

Seminar Briefing: The UK Biotech Sector and Brexit

Read more
  • News
  • January 2018

Seminar Briefing: NHS Agency Staffing and the Impact of Recent Interventions

Read more
  • News
  • August 2017

New OHE Seminar Briefing: Interventions that Encourage High-value Nursing Home Care: Lessons for the UK

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!